A short primer on GLP-1 as a hormone the body makes on its own and how it fits into the body's signaling systems. Evergreen background only.
Recap by typeshit. Post by Facebook on Facebook.
Dr Alo, a cardiologist, says he is following the cardiovascular data on these drugs closely and that it is shifting how heart disease is treated.
50:28
DOWNSIZED looks at why appetite and food noise can creep back late in the weekly cycle, and what that may say about whether a GLP-1 is still working.
Avi Roy points to trial data on drugs like Ozempic, including a 16-week study of 73 people where milkshake ratings barely changed despite reduced appetite.
Research presented at the anesthesiology meeting linked GLP-1 use with lower odds of heart attack and other heart problems. It shows an association, not proof of cause.
With pill versions of obesity drugs now on the market, Dr. Yusupov weighs in on habits people taking them should steer clear of.
Employer coalition HTA found lower disease complexity predicted better results, while some diabetes patients gained weight. Employers may use it to set coverage rules.
Loading…